Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts.
about
Understanding lupus nephritis: diagnosis, management, and treatment options.American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisEfficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapyThe frequency and outcome of lupus nephritis: results from an international inception cohort study.Lupus nephritis in children - 10 years' experience.The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness.Clearing the complexity: immune complexes and their treatment in lupus nephritis.Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus.B-cell depletion in the treatment of lupus nephritis.B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab.Rituximab treatment in lupus nephritis--where do we stand?B-cell targeted therapeutics in clinical development.Rituximab and lupus--a promising pair?Towards new avenues in the management of lupus glomerulonephritis.Rethinking biologics in lupus nephritis.Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review.[Established medications : new areas of application].Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response.Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.Efficacy and toxicity of treatments for nephritis in a series of consecutive lupus patients.
P2860
Q36008840-5FA01B9F-62FF-496A-A3D4-A2C2E5C73C98Q36221407-5EB32761-9C47-415C-8DB4-ACF539A1785AQ36518986-7CA91E05-0E46-4FC5-ACE3-5D33995533BFQ37082037-433FC04D-449F-4CD4-B307-8614E1690008Q37399315-6C193619-4C75-457E-B8A0-5EB6C634D2EBQ37627356-F20F3E1C-362F-4EBE-A778-DD7F2E6A56F2Q37892917-23CA4FE1-6EDB-46FA-A860-DFABDD9E6202Q37954539-1995DB18-FFA3-40D1-B850-9FF7ADC3661BQ37960525-AC6AEBB8-4A0C-460B-9FB9-FB0B2562A86FQ38026784-CFCC7172-87F2-4863-A65E-A9103EBCFFE3Q38051302-AAA6A20C-47D1-400D-A105-CBEC5716D96FQ38095863-15CDB4B1-2610-40C7-8F79-168757CC6896Q38097162-D51CE685-3A9B-428B-BB25-836B6317D98EQ38235185-019B83B5-34A9-4283-9203-E273258B4BE1Q38686467-45325ED0-B94B-4C47-BC3D-001C0377758DQ38833873-4813BA43-7811-4921-8A4A-6F6712BCB31FQ39364970-A6CCB532-CD92-4BB8-8711-D5308CE3FA80Q44480906-CF2980D2-F858-4D98-84F6-4C00B46ADA3FQ46260498-12A37F7B-6391-4BAD-9DD7-0DB1EA32BB88Q50116281-B74A3F23-A5B9-4CDC-9DC7-EE5A82F39B36Q51173136-286482FD-3621-42CC-9D68-27462012FDE0
P2860
Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical improvements in proli ...... pooled data from two cohorts.
@ast
Clinical improvements in proli ...... pooled data from two cohorts.
@en
Clinical improvements in proli ...... pooled data from two cohorts.
@nl
type
label
Clinical improvements in proli ...... pooled data from two cohorts.
@ast
Clinical improvements in proli ...... pooled data from two cohorts.
@en
Clinical improvements in proli ...... pooled data from two cohorts.
@nl
prefLabel
Clinical improvements in proli ...... pooled data from two cohorts.
@ast
Clinical improvements in proli ...... pooled data from two cohorts.
@en
Clinical improvements in proli ...... pooled data from two cohorts.
@nl
P2093
P356
P1433
P1476
Clinical improvements in proli ...... pooled data from two cohorts.
@en
P2093
Ana Filipa Mourão
Iva Gunnarsson
Thórunn Jónsdóttir
P304
P356
10.1093/RHEUMATOLOGY/KEQ055
P577
2010-04-27T00:00:00Z